Investors
Actis to acquire 25% stake in Symbiotec Pharmalab
Actis planned to acquire 25% stake in Symbiotec Pharmalab. Actis, a private equity firm based in London, was looking to acquire a stake in Symbiotec Pharmalab.
Sources: GEA to target sale of private equity unit worth Eur1.3 billion
GEA would target private equity groups with its heat exchanger unit sale worth more than Eur1.3 billion.
Puzey & Payne acquired by management
Puzey & Payne was acquired by its management through a buyout. Puzey & Payne was acquired by its management through a management buyout. This was after the car dealership unit was disposed by its parent group Zimplow Holdings.
Ipsen acquires Syntaxin
Ipsen announced the acquisition of UK-based private life sciences company, Syntaxin. Ipsen announced the acquisition of Syntaxin, a UK-based private life sciences company which specializes in botulinum toxin engineering.